Dados do Trabalho

Título

KETOGENIC DIET FOR THE TREATMENT OF REFRACTORY EPILEPSY IN A TERTIARY CENTER IN NORTHEAST BRAZIL

Introdução

The estimated prevalence of epilepsy is 0.5% - 1% in the global population, with 80% of these individuals living in developing countries where financial resources are generally limited. Approximately 30% of epilepsy patients have shown refractory to adequate drug treatment, requiring the use of alternative treatments such as the ketogenic diet (KD). Therefore, it is important to assess the feasibility of using this type of diet in regions and patients with limited resources

Objetivo

To evaluate adherence, therapeutic response and clinical-epidemiological profile of patients with refractory epilepsy undergoing KD in a tertiary center in northeastern Brazil

Método

A retrospective cross-sectional study was conducted on 32 patients with refractory epilepsy who were followed from June 2020 to December 2022 at the Refractory Epilepsy Outpatient Clinic in northeastern Brazil. Variables analyzed included age, clinical response to the ketogenic diet seizure types, quantity and doses of anti-seizure medications used, route of administration, adherence and adverse effects. The study was approved by the local research ethics under the number number: 65145922.1.0000.5042

Resultados e Conclusões

Forty-three patients were recommended for the KD, of whom 32 initiated the therapy. The majority of patients were female (59.3%), from small town (56.3%), with ages from 3 months to 17 years. Structural (40.6%) and genetic (37.5%) etiologies were the most prevalent and 34% of the sample were using gastrostomy. The frequency of epileptic seizures reduced by at least 50% in most patients (71.9%), and among them, 25% achieved complete seizure control. There was an improvement in neurodevelopmental outcomes (62.2%), reduction in the number of antiepileptic drugs used (25%), as well as in the dosage (50%) administered to the patients. Adherence to the KD was observed in a significant percentage of the sample (71.9%), and adverse effects were present in the minority of cases (28,1%).
CONCLUSION: The KD is a therapeutic strategy for patients with refractory epilepsy, especially for those who are not candidates for surgical treatment, particularly in children. Patients undergoing the KD showed good adherence, low frequency of adverse effects, absence of serious adverse effects, reduction in seizure frequency, and improvement in neurodevelopmental outcomes, even in a tertiary center with limited financial resources in northeastern Brazil.

Palavras Chave

Ketogenic Diet; Refractory Epilepsy; Limited Financial Resources.

Declaração de conflito de interesses de TODOS os autores

All authors declare no conflicts of interest.

Fonte de Fomento (se houver)

Referências (se houver)

1. Azevedo de Lima P, Baldini Prudêncio M, Murakami DK, Pereira de Brito Sampaio L, Figueiredo Neto AM, Teixeira Damasceno NR. Effect of classic ketogenic diet treatment on lipoprotein subfractions in children and adolescents with refractory epilepsy. Nutrition. 2017 Jan;33:271-277.
2. Gallucci Neto J, Marchetti RL. Epidemiologic aspects and relevance of mental disorders associated with epilepsy. Braz J Psychiatry. 2005 Dec;27(4):323-8
3. Noronha, A.L.A., Borges, M.A., Marques, L.H.N., Zanetta, D.M.T., Fernandes, P.T., De Boer, H., Espíndola, J., Miranda, C.T., Prilipko, L., Bell, G.S., Sander, J.W. and Li, L.M. (2007), Prevalence and Pattern of Epilepsy Treatment in Different Socioeconomic Classes in Brazil. Epilepsia, 48: 880-885. https://doi.org/10.1111/j.1528-1167.2006.00974.x
4. Cai QY, Zhou ZJ, Luo R, Gan J, Li SP, Mu DZ, Wan CM. Safety and tolerability of the ketogenic diet used for the treatment of refractory childhood epilepsy: a systematic review of published prospective studies. World J Pediatr. 2017 Dec;13(6):528-536.
5. Sampaio LPB. Ketogenic diet for epilepsy treatment. Arquivos de Neuropsiquiatria [online]. 2016;74(10):842-848
6. Kwan P, Arzimanoglou A, Berg AT, Brodie MJ, Allen Hauser W, Mathern G, Moshé SL, Perucca E, Wiebe S, French J. Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia. 2010 Jun;51(6):1069-77.
7. Wilder, R.M. The effect on ketonemia on the course of epilepsy. Mayo Clin. Bull. 1921, 2, 307. 2. Pulford, D.S. Ketogenic Diets for Epileptics. Calif. West Med. 1927,m27, 50–56
8. Kossoff EH, Zupec-Kania BA, Amark PE et al.; Charlie Foundation, Practice Committee of the Child Neurology Society; Practice Committee of the Child Neurology Society; International Ketogenic Diet Study Group. Optimal clinical management of children receiving the ketogenic diet: recommendations of the International Ketogenic Diet Study Group. Epilepsia. 2009;50:304-17.
9. Freeman JM, Vining EPG, Kossoff EH et al. A blinded, crossover study of the
ketogenic diet. Epilepsia. 2009;50:322-25.
10. Thammongkol S, Vears DF, Bicknell-Royle J et al. Efficacy of ketogenic diet: which epilepsies respond? Epilepsia. 2012;53:e55-9
11. Kossoff EH, McGrogan JR. Worldwide use of the ketogenic diet. Epilepsia. 2005;46:280-9.
12. Vining EP, Freeman JM, Ballaban-Gil K et al. A multicenter study of the efficacy of the ketogenic diet. Arch Neurol. 1998;55:1433-7.
13. Lightstone L, Shinnar S, Callahan CM et al. Reasons for failure of the ketogenic diet. J Neurosci Nurs. 2001;33:292-5.
14. [Kossoff EH, Al-Macki N, Cervenka MC, Kim HD, Liao J, Megaw K, Nathan JK, Raimann X, Rivera R, Wiemer-Kruel A, Williams E, Zupec-Kania BA. What are the minimum requirements for ketogenic diet services in resource-limited regions? Recommendations from the International League Against Epilepsy Task Force for Dietary Therapy. Epilepsia. 2015 Sep;56(9):1337-42. doi: 10.1111/epi.13039. Epub 2015 May 29. PMID: 26033161
15. Freeman JM, Vining EP, Pillas DJ, Pyzik PL, Casey JC, Kelly LM. The efficacy of the ketogenic diet 1998: a prospective evaluation of intervention in 150 children. Pediatrics. 1998;102(6):1358-63. doi:10.1542/peds.102.6.1358
» https://doi.org/10.1542/peds.102.6.1358
16. Wheless JW. History of the ketogenic diet. Epilepsia. 2008;49(Suppl 8):3-5
17. Garcia-Penas JJ. Epilepsia, cognicion y dieta cetogenica [Epilepsy, cognition and ketogenic diet]. Rev Neurol. 2018 Mar 1;66(S01):S71-S75. Spanish. PMID: 29516456
18. IJff DM, Postulart D, Lambrechts DAJE, et al. Cognitive and behavioral impact of the ketogenic diet in children and adolescents with refractory epilepsy: a randomized controlled trial. Epilepsy Behav. 2016;60:153–7.
19. Kossoff EH, Zupec-Kania BA, Auvin S, Ballaban-Gil KR, Christina Bergqvist AG, Blackford R, Buchhalter JR, Caraballo RH, Cross JH, Dahlin MG, Donner EJ, Guzel O, Jehle RS, Klepper J, Kang HC, Lambrechts DA, Liu YMC, Nathan JK, Nordli DR Jr, Pfeifer HH, Rho JM, Scheffer IE, Sharma S, Stafstrom CE, Thiele EA, Turner Z, Vaccarezza MM, van der Louw EJTM, Veggiotti P, Wheless JW, Wirrell EC; Charlie Foundation; Matthew's Friends; Practice Committee of the Child Neurology Society. Optimal clinical management of children receiving dietary therapies for epilepsy: Updated recommendations of the International Ketogenic Diet Study Group. Epilepsia Open. 2018 May 21;3(2):175-192. doi: 10.1002/epi4.12225. PMID: 29881797; PMCID: PMC5983110.
20. Loring DW, Meador KJ. Cognitive side effects of antiepileptic drugs in children. Neurology. Mar 23 2004;62(6):872-877.
21. Glauser TA, Cnaan A, Shinnar S, et al. Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy: initial monotherapy outcomes at 12 months. Epilepsia. Jan 2013;54(1):141- 155. 17.
22. Martin R, Kuzniecky R, Ho S, et al. Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults. Neurology. Jan 15 1999;52(2):321-327
23. Malheiros MF. Perfil epidemiológico e características laboratoriais em crianças e adolescentes com epilepsia refratária candidatos a dieta cetogênica/Atkins modificada atendidos no Ambulatório de Dieta Cetogênica do IMIP. 2019.
24. Breu M, Häfele C, Trimmel-Schwahofer P, Schmidt WM, Laconne F, Vodopiutz J, Male C, Dressler A. The relation of etiology based on the 2017 ILAE classification to the effectiveness of the ketogenic diet in drug-resistant epilepsy in childhood. Epilepsia. 2021 Nov;62(11):2814-2825. doi: 10.1111/epi.17052. Epub 2021 Aug 28. PMID: 34453316; PMCID: PMC9290115
25. Nickels KC, Wirrell EC. Cognitive and social outcomes of epileptic encephalopathies. Semin Pediatr Neurol. 2017;24:264–75
26. Freeman, J.M.; Vining, E.P.; Pillas, D.J.; Pyzik, P.L.; Casey, J.C.; Kelly, L.M. The efficacy of the ketogenic diet 1998: A prospective evaluation of intervention in 150 children. Pediatrics 1998, 102, 1358–1363
27. Hosain SA, La Vega-Talbott M, Solomon GE. Ketogenic diet in pediatric epilepsy patients with gastrostomy feeding. Pediatr Neurol. 2005 Feb;32(2):81-3. doi: 10.1016/j.pediatrneurol.2004.09.006. PMID: 15664765.

Área

Epilepsias